BACKGROUND: There has been constant speculation about the association between metabolic syndrome (MetS) and colorectal neoplasia (CN); however, the published results are conflicting. The aims of this study are to conduct a systematic search, and assess the literature to determine the available evidence on the association between these two conditions. METHODS: Meta-analysis was conducted based on relevant studies identified through a systematic literature review from PubMed, OvidSP, and Cochrane database during January 1980 to July 2011. A combined analysis was performed, followed by a subgroup analyses stratified by the study design, type of colorectal lesions, and sex. Publication bias was assessed using the Begg and Egger tests and visual inspection of funnel plot. RESULTS: Eighteen studies were included in the final analysis. Overall, MetS was associated with 34% increase in the risk of CN [summary relative risk (RR), 1.34; 95% confidence interval (CI), 1.24-1.44]. The association between MetS and CN was found to be statistically significant in separate analysis for both case-control studies (summary RR, 1.58; 95% CI, 1.44-1.73) and cohort studies (summary RR, 1.21; 95% CI, 1.13-1.29). The association remained significant when analyses were restricted by type of colorectal lesions (colorectal cancer: RR, 1.30; 95% CI, 1.18-1.43; colorectal adenoma: RR, 1.37; 95% CI, 1.26-1.49). Further subgroup analysis by sex showed significant association between MetS and CN in both male and female population. CONCLUSIONS: Our meta-analysis showed significant association between presence of MetS and CN. These results may help in identifying high-risk individuals at early stage, who might benefit from targeted colorectal cancer screening intervention.
BACKGROUND: There has been constant speculation about the association between metabolic syndrome (MetS) and colorectal neoplasia (CN); however, the published results are conflicting. The aims of this study are to conduct a systematic search, and assess the literature to determine the available evidence on the association between these two conditions. METHODS: Meta-analysis was conducted based on relevant studies identified through a systematic literature review from PubMed, OvidSP, and Cochrane database during January 1980 to July 2011. A combined analysis was performed, followed by a subgroup analyses stratified by the study design, type of colorectal lesions, and sex. Publication bias was assessed using the Begg and Egger tests and visual inspection of funnel plot. RESULTS: Eighteen studies were included in the final analysis. Overall, MetS was associated with 34% increase in the risk of CN [summary relative risk (RR), 1.34; 95% confidence interval (CI), 1.24-1.44]. The association between MetS and CN was found to be statistically significant in separate analysis for both case-control studies (summary RR, 1.58; 95% CI, 1.44-1.73) and cohort studies (summary RR, 1.21; 95% CI, 1.13-1.29). The association remained significant when analyses were restricted by type of colorectal lesions (colorectal cancer: RR, 1.30; 95% CI, 1.18-1.43; colorectal adenoma: RR, 1.37; 95% CI, 1.26-1.49). Further subgroup analysis by sex showed significant association between MetS and CN in both male and female population. CONCLUSIONS: Our meta-analysis showed significant association between presence of MetS and CN. These results may help in identifying high-risk individuals at early stage, who might benefit from targeted colorectal cancer screening intervention.
Authors: Hiroki Yuhara; Craig Steinmaus; Stephanie E Cohen; Douglas A Corley; Yoshihiro Tei; Patricia A Buffler Journal: Am J Gastroenterol Date: 2011-09-13 Impact factor: 10.864
Authors: Tanja Stocks; Annekatrin Lukanova; Tone Bjørge; Hanno Ulmer; Jonas Manjer; Martin Almquist; Hans Concin; Anders Engeland; Göran Hallmans; Gabriele Nagel; Steinar Tretli; Marit B Veierød; Håkan Jonsson; Pär Stattin Journal: Cancer Date: 2010-12-17 Impact factor: 6.860
Authors: Konstantinos K Tsilidis; Frederick L Brancati; Michael N Pollak; Nader Rifai; Sandra L Clipp; Judith Hoffman-Bolton; Kathy J Helzlsouer; Elizabeth A Platz Journal: Cancer Causes Control Date: 2009-09-23 Impact factor: 2.506
Authors: Krasimira Aleksandrova; Heiner Boeing; Mazda Jenab; H Bas Bueno-de-Mesquita; Eugene Jansen; Fränzel J B van Duijnhoven; Veronika Fedirko; Sabina Rinaldi; Isabelle Romieu; Elio Riboli; Dora Romaguera; Kim Overvad; Jane Nautrup Østergaard; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sophie Morois; Giovanna Masala; Claudia Agnoli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Rudolf Kaaks; Annekatrin Lukanova; Antonia Trichopoulou; Androniki Naska; Christina Bamia; Petra H Peeters; Laudina Rodríguez; Genevieve Buckland; María-José Sánchez; Miren Dorronsoro; Jose-María Huerta; Aurelio Barricarte; Göran Hallmans; Richard Palmqvist; Kay-Tee Khaw; Nicholas Wareham; Naomi E Allen; Konstantinos K Tsilidis; Tobias Pischon Journal: Cancer Prev Res (Phila) Date: 2011-06-22
Authors: Ji Yeon Kim; Yoon Suk Jung; Jung Ho Park; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Kyu Yong Choi; Dong Il Park Journal: World J Gastroenterol Date: 2016-04-07 Impact factor: 5.742